It is evaluated using immunohistochemistry (IHC), and the expression of HER2 protein, encoded by ERBB2 gene, is scored on a scale of 0 to 3+ depending on staining intensity and the percentage of tumor cells positive for HER2 [1]. This evidence concerns the gene ERBB2 and neoplasm.